784 results on '"Porter, Christopher J."'
Search Results
2. Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression
3. Biocompatible Cationic Lipoamino Acids as Counterions for Oral Administration of API-Ionic Liquids
4. Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression
5. micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules
6. Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity
7. Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide
8. Protease-activated receptor-2 in endosomes signals persistent pain of irritable bowel syndrome
9. Endosomal signaling of the receptor for calcitonin gene-related peptide mediates pain transmission
10. Targeting immune cells within lymph nodes
11. Increased In Vivo Exposure of N-(4-Hydroxyphenyl) Retinamide (4-HPR) to Achieve Plasma Concentrations Effective against Dengue Virus
12. An OTX2-PAX3 signaling axis regulates Group 3 medulloblastoma cell fate
13. Establishment of macaque trophoblast stem cell lines derived from cynomolgus monkey blastocysts
14. Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations
15. Minimum information reporting in bio–nano experimental literature
16. Introducing the Molecular Pharmaceutics Special Issue on “Emerging Trends in Molecular Pharmaceutics across Australasia”
17. Data from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
18. Supplementary Tables 3, 7-8 from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
19. Supplementary figures and legends from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
20. Extended Material and Methods from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
21. Supplementary Tables 1-2, 4-6, 9-11 from Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to Chemotherapy
22. Intra-articular Injection of a B Cell Depletion Antibody Enhances Local Exposure to the Joint-Draining Lymph Node in Mice with Collagen-Induced Arthritis
23. MLL1 is required for PAX7 expression and satellite cell self-renewal in mice
24. Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals
25. Corrigendum: Triglyceride-mimetic prodrugs of buprenorphine enhance oral bioavailability via promotion of lymphatic transport
26. Reduced blood‐brain barrier expression of fatty acid‐binding protein 5 is associated with increased vulnerability of APP/PS1 mice to cognitive deficits from low omega‐3 fatty acid diets
27. Lymphatic Absorption of Orally Administered Prodrugs
28. Mtf2-PRC2 control of canonical Wnt signaling is required for definitive erythropoiesis
29. Lipids in the Stomach – Implications for the Evaluation of Food Effects on Oral Drug Absorption
30. Lipid-based Systems, Drug Exposure and Lead Optimization
31. A new in vitro lipid digestion – in vivo absorption model to evaluate the mechanisms of drug absorption from lipid-based formulations
32. A Comparison of the Pharmacokinetics and Pulmonary Lymphatic Exposure of a Generation 4 PEGylated Dendrimer Following Intravenous and Aerosol Administration to Rats and Sheep
33. From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity
34. Fatty Acid Binding Proteins Expressed at the Human Blood–Brain Barrier Bind Drugs in an Isoform-Specific Manner
35. Profiling the Role of Deacylation-Reacylation in the Lymphatic Transport of a Triglyceride-Mimetic Prodrug
36. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase
37. Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport
38. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 6: Effects of Varying Pancreatin and Calcium Levels
39. Endosomal NOX2 oxidase exacerbates virus pathogenicity and is a target for antiviral therapy
40. Model Systems for Intestinal Lymphatic Transport Studies
41. Non-linear Increases in Danazol Exposure with Dose in Older vs. Younger Beagle Dogs: The Potential Role of Differences in Bile Salt Concentration, Thermodynamic Activity, and Formulation Digestion
42. A Mouse Model to Evaluate the Impact of Species, Sex, and Lipid Load on Lymphatic Drug Transport
43. Lipid-Based Formulations and Drug Supersaturation: Harnessing the Unique Benefits of the Lipid Digestion/Absorption Pathway
44. Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations
45. Computational Prediction of Drug Solubility in Lipid Based Formulation Excipients
46. Recent Advances in Lipid-Based Formulation Technology
47. Lipid Absorption Triggers Drug Supersaturation at the Intestinal Unstirred Water Layer and Promotes Drug Absorption from Mixed Micelles
48. A Simple Quantitative Approach for the Determination of Long and Medium Chain Lipids in Bio-relevant Matrices by High Performance Liquid Chromatography with Refractive Index Detection
49. Dendrimers for Biomedical Applications
50. Quantitatively Tracking Bio–Nano Interactions of Metal–Phenolic Nanocapsules by Mass Cytometry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.